Time

Event

8:55 am –  2nd Floor

Welcome
* Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am –  2nd Floor

A Fireside Chat
Extending our Health-Span: The Role of Bioelectronic Medicine
In this talk, Dr. Tracey will explore the vagus nerve’s role and how electrical stimulation is revolutionizing treatment for conditions like Rheumatoid arthritis, Crohn’s disease, even cancer, diabetes and mental health conditions. He will offer an insightful look into the current landscape of bioelectronic medicine, highlighting the devices, research, and clinical trials that are paving the way for a future where healthcare relies on computerized devices delivering targeted electrical therapy instead of conventional medications.

Kevin Tracey, President & CEO, Feinstein Institutes for Medical Research, Northwell Health

Interviewed by:
* Jeremy Abbate, Vice President & Publisher, Scientific American
* Sara Demy, Founder & CEO, Demy-Colton

10:00 am –  12th Floor

Dialogue 3A 
Bioelectronics: Delivering on the Promise of Neuromodulation for Therapeutic Care
In the decade since the field of bioelectronic medicine emerged as a potential alternative to pharmaceuticals, over $1.5 billion dollars in private capital has been invested in neuromodulation startups. Panelists will share signals of progress at their companies and discuss challenges, trends, and commercial momentum in the field.

Moderator: Naveen Rao, Editor-in-Chief, Neurotech Futures

Panel:
* Manfred Franke, PhD, CEO & Co-Founder, Neuronoff
* Yaakov Levine, PhD, Vice President, Research, SetPoint Medical
* Ana Maiques, Co-Founder & CEO, Neuroelectrics
* Shri Raghunathan, PhD, CEO & Co-Founder, Noctrix Health

10:00 am –  Rooftop

Dialogue 3B
The Fight against Cancer: Where are the Next Transformational Breakthroughs Going to Come From?
How do we move the industry forward to improve cancer patient outcomes and where is this going to come from given the headwinds and challenges facing the field? This panel will discuss where we could be in the next 5-10 years in terms of treatment paradigm and overall patient care/outcomes.

Moderator: Jay Campbell, Managing Director, Cancer Research Institute

Panel:
* Jacob Gottlieb, MD, Managing Partner & Chief Investment Officer, Altium Capital Management
* Daina Graybosch, PhD, Senior Managing Director, Biotechnology Analyst, Immuno-Oncology, Leerink 

10:00 am –  12th Floor

One-to-One Meetings

11:00 am –  2nd Floor

Presenting Companies 

12:00 pm –  12th Floor

Dialogue 4A
Tech Innovations of the Future: Deep Tech and AI will Impact Every Aspect of Healthcare
Deep tech and AI are expected to impact almost every aspect of healthcare in the coming years – from predicting the next pandemic, to enabling point of care diagnostics, remote patient monitoring, enhancing drug discovery and other backend systems. This panel of experts will discuss current and new technologies being used in healthcare and the impacts these are expected to have on incumbents and across the healthcare ecosystem.  

Moderator: Beth Rogozinski, CEO, Oncoustics

Panel:
* Vinona Bhatia, MD, MPH, Founder, P4CI Partnering for Cancer Innovation
* Remo Moomiaie-Qajar, MD, President & CEO, Cytonus Therapeutics, Inc
* Georgia Ravitz, Partner, FDA & Healthcare Regulatory, Orrick

12:00 pm –  Rooftop

Dialogue 4B
The Next Frontier of Obesity Care: The Opportunities and Obstacles Ahead for GLP-1s
This session will explore the evolving obesity care landscape given the rise of GLP-1s and how their use may impact healthcare delivery and economics. The conversation will focus on anticipated changes to care paradigms, as well as potential future health and financial implications due to widespread use of GLP-1s. Join us for an in-depth conversation with a panel of experts on navigating the future of GLP-1s, including the opportunities, trade-offs, risks, and complexities, from market disruptions to healthcare system impact.

Moderator: Sari Kaganoff, Chief Commercial Officer, Rock Health

Panel:
* Sloan Saunders, CEO & Co-Founder, Intellihealth
* Greeshma Shetty, MD, Director, Quality and Safety, Virta Health
* Rich Yang, CEO, Biolinq

1:00 pm –  12th Floor

Luncheon

2:00 pm –  2nd Floor

Presenting Companies

2:00 pm –  12th Floor

One-to-One Meetings 

4:30 pm –  12th Floor

Dialogue 5A 

Neurodegenerative Disease Funding: Accelerating Scientific Breakthroughs

Panel:
* Karen Harris, CFO & Head, Mission-Related Investing, The Alzheimer’s Drug Discovery Foundation (ADDF)
* Sean Lorenz, PhD, Senior Director, Product Solutions, Altoida

4:30 pm –  Rooftop

Dialogue 5B 
Unlocking Longevity: Innovations, Investments, and the Future of Biotech

Moderator: Ed Saltzman, Senior Strategic Advisor, Lumanity

Panel:
* Sergei Petukhov, PhD, Founder, Ludicrous Ventures
* Keara Sauber, Managing Director, Sauber Capital

5:30 pm –  Rooftop

End of Day “Big Think" Plenary Session
The Financial Landscape: Are We Coming Out of the Fog? 

Moderator: Stephen Thau, Partner, Co-Head of Life Sciences Practice, Orrick

Panel:
* Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel
* Art Pappas, CEO & Managing General Partner, Pappas Capital
* Dennis Purcell, Founder, Aisling Capital
* Evonne Sepsis, Founder & Managing Director, ESC Advisors

                                               

6:30 pm –  2nd Floor

Evening Reception